Organon To Present at the Piper Sandler 34th Annual Healthcare Conference

Rhea-AI Summary

Organon (NYSE: OGN) will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference on November 29, 2022, at 9:00 a.m. EST. The chat will feature CEO Kevin Ali and CFO Matthew Walsh. Interested parties can listen to the live webcast via this link. Organon focuses on women's health with a diverse portfolio of over 60 medicines and products, supported by a robust cash flow, aiming for innovation and growth.

JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the Piper Sandler 34^th Annual Healthcare Conference on Tuesday, November 29th, 2022 at 9:00 a.m. EST.

Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at https://www.organon.com/investor-relations/events-and-presentations/.

About Organon

Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in innovation and future growth opportunities in women’s health. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey.

For more information, visit http://www.organon.com and connect with us on LinkedIn and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221115005268/en/

Media Contacts:

Karissa Peer

(614) 314-8094

Kate Vossen

(732) 675-8448

Investor Contacts:

Jennifer Halchak

(201) 275-2711

Source: Organon & Co.

FAQ

What event will Organon (OGN) participate in on November 29, 2022?

Organon will participate in the Piper Sandler 34th Annual Healthcare Conference.

Who will represent Organon (OGN) at the Piper Sandler Conference?

CEO Kevin Ali and CFO Matthew Walsh will represent Organon at the conference.

What time is Organon's presentation at the Piper Sandler Conference?

Organon's presentation is scheduled for 9:00 a.m. EST.

Where can I listen to Organon's presentation at the conference?

You can listen to the presentation live via the Organon investor relations website.

What is the focus of Organon's business?

Organon focuses on improving women's health and has a portfolio of over 60 medicines.